Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Hypoxia-selective inhibition of angiogenesis development by NAMI-A analogues.

Oszajca M, Collet G, Stochel G, Kieda C, Brindell M.

Biometals. 2016 Dec;29(6):1035-1046. Epub 2016 Nov 3.

2.

Disrupted Endothelial Cell Layer and Exposed Extracellular Matrix Proteins Promote Capture of Late Outgrowth Endothelial Progenitor Cells.

Zhao J, Mitrofan CG, Appleby SL, Morrell NW, Lever AM.

Stem Cells Int. 2016;2016:1406304. doi: 10.1155/2016/1406304. Epub 2016 Jun 16.

3.

Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation.

Lee CS, Kim YG, Cho HJ, Park J, Jeong H, Lee SE, Lee SP, Kang HJ, Kim HS.

Sci Rep. 2016 Jul 6;6:29393. doi: 10.1038/srep29393.

4.

Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin.

Frye M, Dierkes M, Küppers V, Vockel M, Tomm J, Zeuschner D, Rossaint J, Zarbock A, Koh GY, Peters K, Nottebaum AF, Vestweber D.

J Exp Med. 2015 Dec 14;212(13):2267-87. doi: 10.1084/jem.20150718. Epub 2015 Dec 7.

5.

Nitric Oxide Increases Arterial Endotheial Permeability through Mediating VE-Cadherin Expression during Arteriogenesis.

Yang B, Cai B, Deng P, Wu X, Guan Y, Zhang B, Cai W, Schaper J, Schaper W.

PLoS One. 2015 Jul 2;10(7):e0127931. doi: 10.1371/journal.pone.0127931. eCollection 2015.

6.

Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study.

Doulgere J, Otto B, Nassour M, Wolters-Eisfeld G, Rohde H, Magnus T, Wagener C, Streichert T.

BMJ Open. 2015 Mar 10;5(3):e005659. doi: 10.1136/bmjopen-2014-005659.

7.

The P2Y2 Receptor Interacts with VE-Cadherin and VEGF Receptor-2 to Regulate Rac1 Activity in Endothelial Cells.

Liao Z, Cao C, Wang J, Huxley VH, Baker O, Weisman GA, Erb L.

J Biomed Sci Eng. 2014 Dec 1;7(14):1105-1121.

8.

p18, a novel adaptor protein, regulates pulmonary endothelial barrier function via enhanced endocytic recycling of VE-cadherin.

Chichger H, Duong H, Braza J, Harrington EO.

FASEB J. 2015 Mar;29(3):868-81. doi: 10.1096/fj.14-257212. Epub 2014 Nov 17.

9.

VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration.

Hamilla SM, Stroka KM, Aranda-Espinoza H.

PLoS One. 2014 Oct 2;9(10):e109748. doi: 10.1371/journal.pone.0109748. eCollection 2014.

10.

Brain mesenchymal stem cells: The other stem cells of the brain?

Appaix F, Nissou MF, van der Sanden B, Dreyfus M, Berger F, Issartel JP, Wion D.

World J Stem Cells. 2014 Apr 26;6(2):134-43. doi: 10.4252/wjsc.v6.i2.134. Review.

11.

Endothelial cell permeability and adherens junction disruption induced by junín virus infection.

Lander HM, Grant AM, Albrecht T, Hill T, Peters CJ.

Am J Trop Med Hyg. 2014 Jun;90(6):993-1002. doi: 10.4269/ajtmh.13-0382. Epub 2014 Apr 7.

12.

Sox18 preserves the pulmonary endothelial barrier under conditions of increased shear stress.

Gross CM, Aggarwal S, Kumar S, Tian J, Kasa A, Bogatcheva N, Datar SA, Verin AD, Fineman JR, Black SM.

J Cell Physiol. 2014 Nov;229(11):1802-16. doi: 10.1002/jcp.24633.

13.

VE-cadherin cleavage by LasB protease from Pseudomonas aeruginosa facilitates type III secretion system toxicity in endothelial cells.

Golovkine G, Faudry E, Bouillot S, Voulhoux R, Attrée I, Huber P.

PLoS Pathog. 2014 Mar 13;10(3):e1003939. doi: 10.1371/journal.ppat.1003939. eCollection 2014 Mar.

14.

Isolation, characterization, and transplantation of cardiac endothelial cells.

Pratumvinit B, Reesukumal K, Janebodin K, Ieronimakis N, Reyes M.

Biomed Res Int. 2013;2013:359412. doi: 10.1155/2013/359412. Epub 2013 Oct 27.

15.

Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro.

Paolinelli R, Corada M, Ferrarini L, Devraj K, Artus C, Czupalla CJ, Rudini N, Maddaluno L, Papa E, Engelhardt B, Couraud PO, Liebner S, Dejana E.

PLoS One. 2013 Aug 5;8(8):e70233. doi: 10.1371/journal.pone.0070233. Print 2013.

16.

The "artificial artery" as in vitro perfusion model.

Janke D, Jankowski J, Rüth M, Buschmann I, Lemke HD, Jacobi D, Knaus P, Spindler E, Zidek W, Lehmann K, Jankowski V.

PLoS One. 2013;8(3):e57227. doi: 10.1371/journal.pone.0057227. Epub 2013 Mar 7.

17.

Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells.

Kluger MS, Clark PR, Tellides G, Gerke V, Pober JS.

Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):489-500. doi: 10.1161/ATVBAHA.112.300893. Epub 2013 Jan 3.

18.

The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation.

Timmerman I, Hoogenboezem M, Bennett AM, Geerts D, Hordijk PL, van Buul JD.

Mol Biol Cell. 2012 Nov;23(21):4212-25. doi: 10.1091/mbc.E12-01-0038. Epub 2012 Sep 5.

19.

PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.

Vandenbroucke St Amant E, Tauseef M, Vogel SM, Gao XP, Mehta D, Komarova YA, Malik AB.

Circ Res. 2012 Aug 31;111(6):739-49. doi: 10.1161/CIRCRESAHA.112.269654. Epub 2012 Jul 12.

20.

Phenotypic and functional changes in blood monocytes following adherence to endothelium.

Tso C, Rye KA, Barter P.

PLoS One. 2012;7(5):e37091. doi: 10.1371/journal.pone.0037091. Epub 2012 May 15.

Supplemental Content

Support Center